# Effect of Cabergoline on Endometrial Vascularity During IntraCytoplasmic Sperm Injection

> **NCT02306564** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Kasr El Aini Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Cabergoline

## Key facts

- **NCT ID:** NCT02306564
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2017-11
- **Final completion:** 2017-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2016-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02306564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02306564, "Effect of Cabergoline on Endometrial Vascularity During IntraCytoplasmic Sperm Injection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02306564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*